STAGE IV LUNG CANCER AJCC V8
Clinical trials for STAGE IV LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Drug attack on tough lung cancer tested in small trial
Disease control CompletedThis study tested a combination of three drugs—durvalumab, tremelimumab, and selumetinib—for people with advanced or returning non-small cell lung cancer. The goal was to see if using these drugs together could help the immune system fight the cancer and slow its growth better th…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Virtual therapy trial aims to boost strength and spirits during lung cancer fight
Symptom relief CompletedThis study tested whether a 12-week virtual support program could help older adults with advanced lung cancer feel better physically and emotionally during their cancer treatment. One hundred participants were randomly assigned to either receive the program—which included guided …
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 20, 2026 14:58 UTC
-
New support program aims to ease burden on lung cancer caregivers
Symptom relief CompletedThis study tested a new wellness coaching program designed to support people caring for loved ones with advanced lung cancer. It compared standard support materials to the new coaching sessions to see which better helped caregivers manage stress and burden. The goal was to improv…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 05, 2026 14:00 UTC
-
Scientists bank cancer samples to crack treatment resistance code
Knowledge-focused CompletedThis study collected blood and tumor tissue samples from 64 patients with advanced cancers to build a research library. The goal was to understand why cancers stop responding to treatments and to find better ways to match future patients with effective therapies. Samples were tak…
Matched conditions: STAGE IV LUNG CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC